Selected article for: "ARDS respiratory distress syndrome and clinical spectrum"

Author: Furong Zeng; Ying Guo; Mingzhu Yin; Xiang Chen; Guangtong Deng
Title: Association of inflammatory markers with the severity of COVID-19
  • Document date: 2020_4_17
  • ID: mn3b6nrs_1
    Snippet: The ongoing worldwide pandemic of Coronavirus Disease 2019 has posed a huge threat to global public health (WHO, 2020a) . The pathogen has been identified as a novel single-stranded ribonucleic acid (RNA) betacoronavirus named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which share a great phylogenetic similarity with severe acute respiratory syndrome coronavirus (SARS-CoV) , Zhou P. et al., 2020 . As of March, 21, 2020, a to.....
    Document: The ongoing worldwide pandemic of Coronavirus Disease 2019 has posed a huge threat to global public health (WHO, 2020a) . The pathogen has been identified as a novel single-stranded ribonucleic acid (RNA) betacoronavirus named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which share a great phylogenetic similarity with severe acute respiratory syndrome coronavirus (SARS-CoV) , Zhou P. et al., 2020 . As of March, 21, 2020, a total of 266, 073 confirmed cases from 150 countries and territories were reported, including 11,183 deaths(WHO, 2020b). The COVID-19 represents a spectrum of clinical severity ranged from asymptomatic to critical pneumonia, acute respiratory distress syndrome (ARDS) and even death (Guan et al., 2020) . Therefore, fully monitoring the severity of COVID-19 and effective early intervention are the fundamental measures for reducing mortality.

    Search related documents:
    Co phrase search for related documents